A detailed history of Perceptive Advisors LLC transactions in Immatics N.V. stock. As of the latest transaction made, Perceptive Advisors LLC holds 8,086,159 shares of IMTX stock, worth $57.4 Million. This represents 2.41% of its overall portfolio holdings.

Number of Shares
8,086,159
Previous 8,086,159 -0.0%
Holding current value
$57.4 Million
Previous $94 Million 1.81%
% of portfolio
2.41%
Previous 2.72%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$9.78 - $13.49 $34.3 Million - $47.3 Million
3,503,750 Added 76.46%
8,086,159 $94 Million
Q1 2024

May 15, 2024

BUY
$10.23 - $12.94 $11.2 Million - $14.1 Million
1,090,909 Added 31.24%
4,582,409 $48.2 Million
Q4 2022

Feb 14, 2023

BUY
$8.05 - $11.58 $7.98 Million - $11.5 Million
991,500 Added 39.66%
3,491,500 $30.4 Million
Q3 2020

Nov 16, 2020

BUY
$8.73 - $15.15 $21.8 Million - $37.9 Million
2,500,000 New
2,500,000 $26.5 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $541M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.